MEREO BIOPHARMA - 53 Year Dividend History | MREO
Historical dividend payout and yield for MEREO BIOPHARMA (MREO) since 1971. The current TTM dividend payout for MEREO BIOPHARMA (MREO) as of November 19, 2024 is $0.00. The current dividend yield for MEREO BIOPHARMA as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.490B |
$0.010B |
|
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company's rare disease product candidates, setrusumab for the treatment of osteogenesis imperfecta and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease. Mereo BioPharma Group plc is based in LONDON.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
